
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FIG4 CRISPR/Cas9 KO Plasmid (h) | sc-404404 | 20 µg | $397.00 |
FIG4 encodes a phosphoinositide 5-phosphatase that regulates turnover of phosphatidylinositol 3,5-bisphosphate and related lipids on endolysosomal membranes. Through its participation in PIKfyve–VAC14–FIG4 regulatory complexes, FIG4 influences endosome-to-lysosome trafficking, autophagy, membrane recycling, and maintenance of lysosomal homeostasis. Perturbation of FIG4 activity disrupts endolysosomal dynamics and cellular stress responses, processes central to neuronal maintenance and myelin integrity. Human genetic studies link FIG4 dysfunction to neurodegenerative and neurodevelopmental phenotypes, supporting its importance in membrane trafficking pathways relevant to nervous system biology.
FIG4 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the FIG4 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the FIG4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the FIG4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish FIG4 protein expression.
This CRISPR knockout system enables efficient generation of FIG4-deficient cell models for investigation of FIG4 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.